ovenerio

# I Believe AstraZeneca Is Fairly Valued

July 16, 2014 | About:

AstraZeneca PLC (NYSE:AZN), a \$94.71 billion market cap company is a giant in the drug industry and has a trailing P/E ratio that indicates that the stock is relatively undervalued (22.7x vs 41.8x of industry mean). So in this article, let's take a look at a model which is applicable to stable, mature, dividend-paying firms and try to find the intrinsic value of the stock. Although the model has a number of characteristics that make it useful and appropriate for many applications, is by no means the be-all and end-all for valuation. The purpose is to force investors to evaluate different assumptions about growth and future prospects.

Valuation

In stock valuation models, dividend discount models (DDM) define cash flow as the dividends to be received by the shareholders. Extending the period indefinitely, the fundamental value of the stock is the present value of an infinite stream of dividends according to John Burr Williams.

Although this is theoretically correct, it requires forecasting dividends for many periods, so we can use some growth models like: Gordon (constant) growth model, the Two or Three stage growth model or the H-Model (which is a special case of a two-stage model). With the appropriate model, we can forecast dividends up to the end of the investment horizon where we no longer have confidence in the forecasts and then forecast a terminal value based on some other method, such as a multiple of book value or earnings.

To start with, the Gordon Growth Model (GGM) assumes that dividends increase at a constant rate indefinitely.

This formula condenses to: V0=(D0 (1+g))/(r-g)=D1/(r-g)

where:

V0 = fundamental value

D0 = last year dividends per share of Exxon's common stock

r = required rate of return on the common stock

g = dividend growth rate

Let´s estimate the inputs for modeling:

Required Rate of Return (r)

The capital asset pricing model (CAPM) estimates the required return on equity using the following formula: required return on stock j = risk-free rate + beta of j x equity risk premium

Assumptions:

Risk-Free Rate: Rate of return on LT Government Debt: RF = 2.67%. This is a very low rate because of today´s context. Since 1900, yields have ranged from a little less than 2% to 15%; with an average rate of 4.9%. So I think it is more appropriate to use this rate.

Beta: β =0.64

GGM equity risk premium = (1-year forecasted dividend yield on market index) + (consensus long-term earnings growth rate) – (long-term government bond yield) = 2.13% + 11.97% - 2.67% = 11.43%[1]

rAZN = RF + βAZN [GGM ERP]

= 4.9% + 0.83 [11.43%]

= 14.39%

Dividend growth rate (g)

The sustainable growth rate is the rate at which earnings and dividends can grow indefinitely assuming that the firm´s debt-to-equity ratio is unchanged and it doesn´t issue new equity.

g = b x ROE

b = retention rate

ROE can be estimated using Dupont formula: ROE=(Net Income)/Equity= ((Net Income)/Sales).(Sales/(Total Assets)).((Total Assets)/Equity)

The “PRAT” Model: g= ((Net Income-Dividends)/(Net Income)).((Net Income)/Sales).(Sales/(Total Assets)).((Total Assets)/Equity)

Let´s collect the information we need to get the dividend growth rate:

 Financial Data (USD \$ in millions) Dec. 2013 Dec. 2012 Dec. 2011 Cash dividends declared 3,461,000 3,665,000 3,764,000 Net income applicable to common shares 2,571,000 6,270,000 9,950,000 Net sales 25,711,000 27,973,000 33,591,000 Total assets 55,899,000 53,534,000 52,830,000 Total Shareholders' equity 23,224,000 23,731,000 23,240,000 Ratios Retention rate -0.35 0.42 0.62 Profit margin 0.10 0.22 0.30 Asset turnover 0.46 0.52 0.64 Financial leverage 2.38 2.28 2.27 Retention rate = (Net Income – Cash dividends declared) ÷ Net Income = -0.35 Profit margin = Net Income ÷ Net sales = 0.10 Asset turnover = Net sales ÷ Total assets = 0.46 Financial leverage = Total assets ÷ Total Shareholders' equity = 2.41 Averages Retention rate 0.23 Profit margin 0.21 Asset turnover 0.54 Financial leverage 2.31 g = Retention rate × Profit margin × Asset turnover × Financial leverage Dividend growth rate 5.94%

Because for most companies, the GGM is unrealistic, let´s consider the H-Model which assumes a growth rate that starts high and then declines linearly over the high growth stage, until it reverts to the long-run rate. A smoother transition to the mature phase growth rate that is more realistic.

Dividend growth rate (g) implied by Gordon growth model (long-run rate)

With the GGM formula and simple math: g=(P0.r - D0)/(P0+D0)

= (\$74.86 ×14.39% – \$3.8) ÷ (\$74.86 + \$3.8) = 8.86%.

The growth rates are:

 Year Value g(t) 1 g(1) 5.94% 2 g(2) 6.67% 3 g(3) 7.40% 4 g(4) 8.13% 5 g(5) 8.86%

G(2), g(3) and g(4) are calculated using linear interpolation between g(1) and g(5).

Calculation of Intrinsic Value

 Year Value Cash Flow Present value 0 Div 0 3.80 1 Div 1 4.03 3.52 2 Div 2 4.29 3.28 3 Div 3 4.61 3.08 4 Div 4 4.99 2.91 5 Div 5 5.43 2.77 5 Terminal Value 106.95 54.61 Intrinsic value 70.18 Current share price 74.86

Final Comment

We found that the intrinsic value is 6% lower than the share price, so we can say that the stock is overvalued and it makes sense to sell the stock. But, using a margin of safety (usually 20%), we can conclude the stock is fairly valued.

We have covered just one valuation method and investors should not be relied on alone in order to determine a fair (over/under) value for a potential investment.

Hedge fund gurus have also been active in the company. Joel Greenblatt (Trades, Portfolio), John Hussman (Trades, Portfolio), David Dreman (Trades, Portfolio) and Murray Stahl (Trades, Portfolio) have taken long position in the stock in the first quarter of 2014.

Disclosure: Omar Venerio holds no position in any stocks mentioned.

[1] This values where obtained from Blommberg´s CRP function.

### About the author:

ovenerio
Omar Venerio is capital markets, derivatives, corporate finance and financial management professor. He is passionate about the stock market and providing independent fundamental research and hedge fund and insider trading-focused investigation.

 Currently 0.00/512345 Rating: 0.0/5 (0 votes)

### Comments

#### Please leave your comment:

GuruFocus has detected 8 Warning Signs with AstraZeneca PLC \$AZN.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.

### →User Generated Screeners

star1907 Good company's Best dividends charlie Spunar Div CDT INDEX buffet MY VALUE prova dcf overwrite 'Dividend Initiation Dividend Initiation Dividend Growth
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to \$400 per referral. ( Learn More)